Silvio Veronese
Overview
Explore the profile of Silvio Veronese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
7185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Baliakas P, Mattsson M, Hadzidimitriou A, Minga E, Agathangelidis A, Sutton L, et al.
Haematologica
. 2017 Dec;
103(4):e158-e161.
PMID: 29269523
No abstract available.
12.
Milione M, Ardini E, Christiansen J, Valtorta E, Veronese S, Bosotti R, et al.
Oncotarget
. 2017 Sep;
8(33):55353-55360.
PMID: 28903424
In colorectal cancer patients, chromosomal rearrangements involving gene (encoding the TRKA protein) are shown in a small subset of patients and are associated with the constitutive activation of the kinase...
13.
Sartore-Bianchi A, Amatu A, Bonazzina E, Stabile S, Giannetta L, Cerea G, et al.
Target Oncol
. 2017 Jul;
12(4):525-533.
PMID: 28669023
Background: Patients with metastatic colorectal cancer (mCRC) refractory to standard therapies have a poor prognosis. In this setting, recruitment into clinical trials is warranted, and studies driven by selection according...
14.
Xochelli A, Baliakas P, Kavakiotis I, Agathangelidis A, Sutton L, Minga E, et al.
Clin Cancer Res
. 2017 May;
23(17):5292-5301.
PMID: 28536306
We sought to investigate whether B cell receptor immunoglobulin (BcR IG) stereotypy is associated with particular clinicobiological features among chronic lymphocytic leukemia (CLL) patients expressing mutated BcR IG (M-CLL) encoded...
15.
Pennisi M, Cesana C, Cittone M, Bandiera L, Scarpati B, Mancini V, et al.
Case Rep Hematol
. 2017 Apr;
2017:4984951.
PMID: 28409040
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with aggressive clinical course and poor prognosis. Diagnosis is based on detection of CD4 CD56, CD123, TCL-1, and blood...
16.
Tosi F, Magni E, Amatu A, Mauri G, Bencardino K, Truini M, et al.
Clin Colorectal Cancer
. 2017 Feb;
16(3):e153-e163.
PMID: 28216246
Background: The purpose of the study was to evaluate whether the mutational status of Kirsten rat sarcoma viral oncogene homolog (KRAS) or b-viral oncogene homolog B1 (BRAF) could be an...
17.
Fujii T, Barzi A, Sartore-Bianchi A, Cassingena A, Siravegna G, Karp D, et al.
Clin Cancer Res
. 2017 Jan;
23(14):3657-3666.
PMID: 28096270
Tumor-derived cell-free DNA (cfDNA) from urine of patients with cancer offers noninvasive biological material for detection of cancer-related molecular abnormalities such as mutations in Exon 2 of A quantitative, mutation-enrichment...
18.
Sartore-Bianchi A, Valtorta E, Amatu A, Veronese S, Lauricella C, Bonazzina E, et al.
ESMO Open
. 2016 Nov;
1(4):e000079.
PMID: 27843629
No abstract available.
19.
Moroni M, Stella M, Pedrazzoli P, Pirovano M, Boveri E, Veronese S
Acta Oncol
. 2016 Sep;
55(11):1373-1375.
PMID: 27579625
No abstract available.
20.
Sartore-Bianchi A, Trusolino L, Martino C, Bencardino K, Lonardi S, Bergamo F, et al.
Lancet Oncol
. 2016 Apr;
17(6):738-746.
PMID: 27108243
Background: We previously found that dual HER2 blockade with trastuzumab and lapatinib led to inhibition of tumour growth in patient-derived xenografts of HER2-amplified metastatic colorectal cancer. In this study, we...